BGMS (cyclacel.com) Enterprise Value-to-Revenue Coefficient

Official company branding of Bio Green Med Solution Inc. (BGMS)

Bio Green Med Solution Inc is implementing green chemistry principles and systematically developing its R&D portfolio of transcription inhibitors. The EV/Sales valuation multiple helps filter out market noise, with the current value standing at 269.06. The business relies on clinics and laboratories, expanding its reach by creating effective therapy protocols for blood tumors.

cyclacel.com (BGMS): EV/Sales Multiple from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Bio Green Med Solution (BGMS)

- business market valuation indicators:
Fundamental company valuation:Bio Green Med Solution Inc BGMS
Product sample of cyclacel.com

For the biotechnology sector, where the stability of Bio Green Med Solution Inc (BGMS) depends on external financing and the success of oncology research, controlling asset overvaluation is critical. Analyzing the EV/Sales valuation chart, an investor can see the real value of the business relative to revenue without the influence of debt; the current value of 269.06 makes it possible to determine whether the market is overpaying for the company's potential amid the Fed's tight monetary policy.